SPON2 and gastric cancer: Recently, SPON2 overexpression was found in numerous tumors including hepatocellular carcinoma [20], colorectal cancer [21], gastric cancer [22], prostate cancer [23], ovarian cancer [24], pancreatic cancer [25], and pulmonary adenocarcinoma [12].